close

Enter

Log in using OpenID

Clinical Trials Imaging Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
Interpretable human physiology and anatomy information plays an important role in both clinical and non-clinical trials for many years. Detecting, preventing and treating various ailments often fosters healthcare trends. Clinical references in terms
Clinical Trials Imaging Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
Interpretable human physiology and anatomy information plays an important role in
both clinical and non-clinical trials for many years. Detecting, preventing and treating
various ailments often fosters healthcare trends. Clinical references in terms of
clinical imaging provide vital insights about drug effects. Hence clinical trial imaging
market is flourishing particularly when it comes to research and drug development
organisations. The global clinical trial imaging market is estimated to experience
profitable growth during the forecast period from 2019 to 2026 registering global
CAGR of 6.5%.
Potential upsurge in the number of pharma and biotechnology players, research
organizations, increase in aged population with chronic diseases along with
favourable R&D investments is expected to drive the growth clinical trial imaging
market during the forecast period.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=109&page=requestsample
Clinical Trails Imaging Market Drivers Overview:
1. Advancement in Imaging Technology
Numerous technology patents are being filled in an attempt to improve image
capturing and evaluation by core imaging labs in order to speed up the development
time for pharmaceutical organisations. Data accuracy, adaptability, consistency and
compliance to clinical studies is possible due to the latest image analysis software.
Advanced technology along with exceptional computation options enables rapid
improvements in collection, assessment and submission of clinical trial data.
2. Emerging Pharmaceutical and Biotechnology Industry
Medical imaging experiences fluctuations every now and then, yet numerous
pharmaceutical and biotechnology companies continue to emerge. Also increasing
investment in R&D for developing and discovering new drugs serves as a key driver in
clinical trials imaging market upthrust.
3. Mergers and Acquisitions
Not only investments in pharma and biotech firms but also the mergers and
acquisitions among medical imaging companies are forging ways to enhance clinical
trials imaging market.
4. High-Cost Imaging Systems and Implementation Barriers
Adoption of innovative imaging technologies to support clinical trials for medical
devices comes at a cost. Latest machinery, their installation, setting up mechanisms
to transfer scans to a central location incur a high cost as well as high capital required
to run clinical trials. Drug discoveries are augmenting the growth of clinical trials
which involves imaging guidance documentation, managing quality assurance,
performing quality control on scans received and the organization of independent
radiological review and/or image analysis involves experts who need to be paid.
These factors can restrain the growth of the market.
Clinical Trails Imaging Market Report Overview:
• Imaging Type Segment
o Computed Tomography (CT) Scan
o Magnetic Resonance Imaging (MRI)
o X-Ray
o Ultrasound
o Echocardiography
• End-Users
o Bio-Pharmaceutical companies
o Medical Devices Manufacturers
o Academic Institutes
o CROs i.e Contract Research Organizations
o Hospitals
o Others (cosmetics and skin care companies)
Purchase a Copy of this Premium Research Report At:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=109&license=single
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on global clinical trials imaging market by
imaging type, end-user and region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
Merin John
Merin John263   documents Email
Document
Category
Health and Medicine
Views
5
File Size
16 KB
Tags
healthcare, health, Health & Medicine
1/--pages
Report inappropriate content